Corner Therapeutics raised $54 million in a Series A funding led by Ziff Capital Partners to create vaccines that confer lifelong protection from cancer and infectious diseases.
Amount Raised
$54 Million
Round Type
Series A
WatertownBiotechnologyHealth CareTherapeuticsresearchInvestors
Description
US immune therapies and vaccines developer Corner Therapeutics has raised $54 million in a Series A funding to create vaccines that confer lifelong protection from cancer and infectious diseases.
Quick answer
Corner Therapeutics raised $54 Million in a Series A round, dated April 19, 2024. Investors: Sandia Holdings, Tanis Ventures, Cockrell Interests and Ziff Capital Partners. Corner Therapeutics is based in Watertown, Massachusetts, United States.
- How much did Corner Therapeutics raise?
- Corner Therapeutics raised $54 Million in a Series A round on April 19, 2024.
- Who invested in Corner Therapeutics?
- Sandia Holdings, Tanis Ventures, Cockrell Interests and Ziff Capital Partners are named as investors in this round.
- What does Corner Therapeutics do?
- Corner is pioneering a new class of immunotherapies.
- Where is Corner Therapeutics based and how big is it?
- Corner Therapeutics is based in Watertown, Massachusetts, United States. Fundz records about 35 employees.
- Who are the decision-makers at Corner Therapeutics?
- Fundz holds 2 contacts at Corner Therapeutics, including the Chief Financial Officer, Chief Business Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and research around the same time
Companies in the same sectors as Corner Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Aptose Biosciences raised $4.4M (Seed) on June 3, 2024.
- BioLineRx Ltd raised $20M (Pre-Seed) on April 10, 2024.
- Calidi Biotherapeutics raised $5.5M on June 3, 2024.
- Summit Therapeutics raised $200M on June 3, 2024.
- Radiomer Therapeutics raised an undisclosed amount (Pre-Seed) on May 29, 2024.
- Gameto raised $33M (Series B) on May 29, 2024.
Who to call at Corner Therapeutics, and when
A new round usually means Corner Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Corner Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Corner Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Corner Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Corner Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCorner Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.